Nervous system meds

download Nervous system meds

of 110

Transcript of Nervous system meds

  • 8/13/2019 Nervous system meds

    1/110

    Medications Affecting theNervous System

    (Classifications)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    2/110

    Muscarinic agonists (parasympathomimetic) Bethanechol

    Muscarinic antagonists Atropine

    Ganglionic-stimulating agents Nicotine

    Cholinesterase inhibitors (ChE) Physostigmine or neostigmine

    Neuromuscular-blocking agents Tubocurarine

    Arenergic agonists (sympathomimetic) Epinephrine

    Arenergic antagonistsblock ! " # receptors$

    Pra%osin ! arenergic antagonist

    Propanolol # arenergic antagonist

  • 8/13/2019 Nervous system meds

    3/110

    NicotinicN#ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    4/110

    &elease o' epinephrine 'rom arenal meulla

  • 8/13/2019 Nervous system meds

    5/110

    NicotinicM#ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    6/110

    ocate at neuromuscular unction o' skeletal muscle

    Causes skeletal muscle contraction

  • 8/13/2019 Nervous system meds

    7/110

    Muscarinic #ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    8/110

    secretions 'rom lungs* stomach* intestines* s+eat glans

    in ,&

    mooth muscle contraction in bronchi an G. tract

    Miosis (sphincter contraction) an accommoation (ciliary contra

    /oiing ue to contraction o' etrusor muscle an rela0ation o' tran sphincter muscles

  • 8/13/2019 Nervous system meds

    9/110

    Al$ha1#ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    10/110

    Myriasis 1t raial muscle contraction

    /eins an arterioles are acti2ate to constrict

    peripheral resistance*bloo pressure

    Male se0 organs are acti2ate to promote eaculation

    Contraction o' prostatic capsule* trigone* an sphincter muscles

  • 8/13/2019 Nervous system meds

    11/110

    %o$amine #ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    12/110

    3ilates bloo 2essels in the kineys

  • 8/13/2019 Nervous system meds

    13/110

    &eta1#ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    14/110

    Preominant receptor 'oun on the heart

    ,&*Contraction 4orce* Conuction through A/ noe

    lipolysis

    &elease o' &enin by the kineys

  • 8/13/2019 Nervous system meds

    15/110

    &eta2#ece$tors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    16/110

    3ilates bronchi &ela0es uterine smooth muscle

    /asoilation o' arterioles in heart* lungs* an skeletal muscle

    lightlyperipheral resistance

    glycogenolysis in the li2er an muscles

    keletal muscle contraction

  • 8/13/2019 Nervous system meds

    17/110

    Medications Affecting theNervous System

    ('eneral oints)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    18/110

    Aapti2e changes +ithin brain +ith prolonge e0posure therapeutic e''ect

    sie e''ects

    Tolerance* physical epenence

    3o not stop abruptly

    ,ighly 2ariable ini2iual response to meiations

  • 8/13/2019 Nervous system meds

    19/110

    arinson*s %isease

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    20/110

    Treatment uses t+o main classes5

    Mes that acti2ate opamine receptors (irectly or inirectly)

    Mes that block acetylcholine receptors

  • 8/13/2019 Nervous system meds

    21/110

    Sei+ure %isorders

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    22/110

    6 types o' sei%ures respon to 6 meications

    7sually re8uire li'e-long management

    Mes must be iscontinue slo+ly o2er 9 +eeks to se2eral month

  • 8/13/2019 Nervous system meds

    23/110

    Schi+o$hrenia

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    24/110

    Clinical course inclues semi-remission punctuate by acutee0acerbations

    Positi2e symptoms (Agitation* elusions)

    Con2entional antipsychotic Thora%ine

    Atypical antipsychotic Clo%apine

    Negati2e symptoms (ocial +ithra+al* poor sel'-care)

    Atypical antipsychotic Clo%apine Cogniti2e symptoms (3i''iculties +ith memory an learning)

    .nitial oses are high an gi2en throughout ay: maintenance oseat betime$

  • 8/13/2019 Nervous system meds

    25/110

    %e$ression

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    26/110

    ymptom relie' can take ;-< +eeks an possibly =-< months

    Three main groups5

    Tricyclic antiepressants (TCAs)

    electi2e serotonin reuptake inhibitors (&.s)

    Monamine o0iase inhibitors (MA>.s)

  • 8/13/2019 Nervous system meds

    27/110

    &i$olar %isorder

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    28/110

    Typically manage +ith mood stabilizers$ Antipsychotics anantiepressants may be use uring acute episoes o' mania orepression$

    ithium

    /alproic aci (3epakote) Carbama%epine (Tegretol)

  • 8/13/2019 Nervous system meds

    29/110

    Cholinesterase Inhi,itors

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    30/110

    Expected Action: Proto:Neostigmine* Phy

    Pre2ents ACh egraation transmission o' ner2e impulses by ?A

    Therapeutic Uses:

    muscle strength by

    ?ACh@ at neuromuscular unction in myastheni

    &e2ersal o' nonepolari%ing neuromuscular blocking agents (tubocurarin

    Adverse Effects:

    E0cessi2e muscarinic stimulation5 G. motility " secretions* braycarurinary urgency (sie e''ect can be treate +ith atropine)

    Cholinergic crisis5 Abo2e plus resp$ epression 'rom neuromuscular blo

    Contraindications/Precautions: Pregnancy (C)

    C. in obstruction o' G.1G7 systems 1 caution +ith sei%ures* asthma* brahypotension* peptic ulcer isease

    Interactions: Tubocurarine Neostigmine re2erses blockae Atropine counteracts uccinylcholine - neuromuscular block

    Education: ear meic-alert bracelet

  • 8/13/2019 Nervous system meds

    31/110

    Neuromuscular &locingAgents

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    32/110

    Expected Action:Proto:Nonepolari%ing5 tubocurarine* pa

    3epolari%ing5 succ

    Block ACh at neuromuscular unction ont cross bloo-brain barrier

    Therapeutic Uses: Control spontaneous respiration in 2entilate pts$

    Auncts to general anesthesia 3iagnose myasthenia gra2is

    uccinylcholine 'or5 electrocon2ulsi2e therapy* intubation* enoscopy

    Adverse Effects: ,ypotension 'rom histamine release " ganglionic blo

    &espiratory arrest Braycaria* ysrhythmias

    Succinylcholine: o+ pseuocholinesterase acti2ity apnea

    Malignant hyperthermia (antrolene) Pain ,ypeContraindications/Precautions: Pregnancy (C)

    Ch5 C. 'or hyperkalemia (trauma* burns)

    Interactions: General anesthetics

    Aminoglycosies1tetracyclines - NM blockae

    Neostigmine1ChE inhibitors5 D nonepolari%ing 1 D epolari%ing

  • 8/13/2019 Nervous system meds

    33/110

    %o$aminergics(Anti"arinson*s)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    34/110

    Expected Action: Proto:e2oopa* carbiopa

    e2oopa taken up an con2erte to opamine$ Carbiopa augments le2

    pre2enting con2ersion to opamine in intestine an periphery (?3A@ i

    Therapeutic Uses: ymptomatic relie' 'rom yskinesias

    Adverse Effects: 3yskinesias 3iscoloration o' s+eat " urine

    Nausea 1 ro+siness >rthostatic hypotension

    Psychosis (clo%apine) Acti2ation o' malignant mel

    Contraindications/Precautions: F cariac or psychiatric isorers

    C. F melanoma = +eeks 'rom MA>. Pregnancy (C)

    Interactions: Proteins inter'ere +ith absorption an transport

    Con2entional antipsychotics (halol* compa%ine) D

    Pyrio0ine

    D MA>. hypertension

    Carbiopa* opamine agonists* anticholinergics* C>MT inhibitors an

    releaserstherapeutic e''ects$

  • 8/13/2019 Nervous system meds

    35/110

    C-MT

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    36/110

    Catechol >-Methyltrans'erase

    3eacti2ates catecholamines (opamine* norepinephrine* acetylchoepinephrine* serotonin* histamine* etc)

    4oun in post-synaptic cell membranes o' arenergic neurons +h

    egraes norepinephrine$

    Also 'oun in gut

  • 8/13/2019 Nervous system meds

    37/110

    %o$amine Agonists(Anti"arinson*s)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    38/110

    Expected Action: Proto:Pramipe0ole* ropinirole* bro

    Act irectly on opamine receptors

    Therapeutic Uses:

    Monotherapy early 1 combine +ith le2oopa in later stages

    Adverse Effects: >rthostatic hypotension Psychosis

    leep attacks 3aytime sleepiness 3yskinesias Naus

    Contraindications/Precautions: Pregnancy (C)

    Caution F li2er " kiney impairment

    Interactions:

    e2oopa5 Can motor-control 'luctuations permitting lo+er ose

    e2oopa5 Also risk o' orthostatic hypotension an yskinesias

    Education:

  • 8/13/2019 Nervous system meds

    39/110

    Centrally ActingAnticholinergics

    (Anti"arinson*s)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    40/110

    Expected Action: Proto:Ben%tropine (Cogentin)* trihe0ypheni

    Block ACh at muscarinic receptors +hich helps maintain ACh* opamin

    Adverse Effects: Nausea (take F 'oo)

    Atropine-like e''ects (ry mouth* blurre 2ision* myriasis* constipation

    Antihistamine e''ects (seation* ro+siness)

    Contraindications/Precautions:

    C. in narro+-angle glaucoma

    Interactions:

    Education:

  • 8/13/2019 Nervous system meds

    41/110

    Antiviral(Anti"arinson*s)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    42/110

    Expected Action: Proto:A

    timulate opamine release* pre2ent opamine reuptake* an may block

    cholinergic an glutamate receptorsTherapeutic Uses: Parkinsons 3isease

    Adverse Effects: CN E''ects 3iscoloration o' skin (temporary)

    Atropine-like e''ects

    Contraindications/Precautions:

    Interactions:

    Education:

  • 8/13/2019 Nervous system meds

    43/110

    Antie$ile$tic Medications(Medication .ist)

    N203ATI (nit

    Nervous Sys

    Barbiturates phenobarbital (uminal)

    ,yantoins phenytoin (3ilantin)

  • 8/13/2019 Nervous system meds

    44/110

    ,yantoins phenytoin (3ilantin)

    Ben%oia%epines ia%epam (/alium)

    $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$ora%epam (Ati2an)

    $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$Carbama%epine (Tegretol)

    $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$Ethosu0imie (arontin)

    $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$/alproic aci (3epakote)

    $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$Gabapentin (Neurontin)

    >ther mes lamotrigine (amictal)

    $$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$$o0carba%epine (Trileptal)

  • 8/13/2019 Nervous system meds

    45/110

    &ar,iturate(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    46/110

    Therapeutic Uses: Proto:Phenobarbita

    Partial sei%ures an generali%e tonic-clonic sei%ures

    Not e''ecti2e against absence sei%uresAdverse Effects:

    CN e''ects5 Aults as seation an an0iety* kis as irritability an hype

    To0icity5 Nystagmus* ata0ia* respiratory epression* pinpoint pupils

    Contraindications/Precautions: Pregnancy (3)

    C. F intermittent porphyria

    Interactions:

    Education:

  • 8/13/2019 Nervous system meds

    47/110

    /ydantoins(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    48/110

    Therapeutic Uses: Proto:Phenytoin

    E''ecti2e against all maor 'orms e0cept absence sei%ures

    Adverse Effects: CN e''ects kin rash Teratogenic Gingi2al hyperp

    Cario2ascular Enocrine e''ects /itamin 3 me

    Contraindications/Precautions:

    C.5 sinus braycaria* A blocks* =n" ral contracepti2es* +ar'arin* glucocorticois5

    D o' the Et>,* ia%epam* cimetiine* 2alproic aci5 phenytoin le2els

    Carbama%epine* phenobarbital* chronic Et>,5 phenytoin le2els

    CN epressants (e$g$ barbiturates1Et>,)5 Aiti2e e''ects +ith concurr

    Education: 7se ./ route 'or status epilepticus Antiysrhythmics

  • 8/13/2019 Nervous system meds

    49/110

    Car,ama+e$ine(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    50/110

    Therapeutic Uses: Prot

    Partial sei%ures* tonic-clonic sei%ures* bipolar isorer* trigeminal neural

    Adverse Effects: kin isorers

    Cogniti2e 'unction is minimally a''ecte but CN e''ects can occur Bloo yscrasias Teratogenic ,ypo-osmolarity (A3, se

    Contraindications/Precautions:

    C.5 marro+ suppression 1 bleeing isorers

    Interactions: Grape'ruit uice5 inhibits metabolism ?carbama%epine@

    Phenytoin " phenobarbital5 D carbama%epine >ral contracepti2es an +ar'arin5 Carbama%epine stimulates hepatic en%

    +hichle2els o' these meications

    Education:

  • 8/13/2019 Nervous system meds

    51/110

    thosu1imide(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    52/110

    Therapeutic Uses: Prot

    .nicate >NH 'or absence sei%ures

    Adverse Effects:

    G. e''ects (take F 'oo)

    CN e''ects ('atigue* i%%iness)

    Contraindications/Precautions:

    Interactions:

    Education:

  • 8/13/2019 Nervous system meds

    53/110

    al$roic Acid(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    54/110

    Therapeutic Uses: Proto

    Partial* generali%e* an absence sei%ures* bipolar isorer* an migraine

    Adverse Effects:

    G. e''ects (take F 'oo) ,epatoto0icity Thrombocyt

    Pancreatitis as e2ience by nausea* 2omiting* an abominal pain

    Contraindications/Precautions:

    A2oi in chilren younger than < (hepatoto0icity) i2er isorers

    Interactions:

    Phenytoin an phenobarbital5 Concurrent use these meications

    Education:

  • 8/13/2019 Nervous system meds

    55/110

    'a,a$entin(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    56/110

    Therapeutic Uses: Proto

    ingle agent use 'or partial sei%ures

    Neuropathic pain

    MigraAdverse Effects:

    CN e''ects (ro+siness* nystagmus)

    Contraindications/Precautions:

    Interactions:

    Education:

  • 8/13/2019 Nervous system meds

    57/110

    &en+odia+e$ines(Antie$ile$tic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    58/110

    Therapeutic Uses: Proto:3ia%epam

    7se in status epilepticus

    Adverse Effects: &espiratory epression

    Anterograe amnesia

    Teratogenic

    Contraindications/Precautions:

    Interactions:

    Education:

  • 8/13/2019 Nervous system meds

    59/110

    Muscle #ela1ants Antis$asmodics

    (Medication .ist)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    60/110

    Centrally Acting Muscle Relaxants

    3ia%epam (2alium) Baclo'en (ioresal) Cycloben%aprine (4le0eril) Meta0alone (kela0in)

    Peripherally Acting Muscle Relaxants

    3antrolene (3antrium)

  • 8/13/2019 Nervous system meds

    61/110

    %ia+e$am(Muscle #ela1ant Antis$asmodic)

    N203ATI (nit

    Nervous Sys

    Expected Action: Proto:3ia%epam

  • 8/13/2019 Nervous system meds

    62/110

    Acts in CN to enhance GABA an prouce seation

    Acts in CN to epress spasticity o' muscles

    Therapeutic Uses: &elie' o' spasticity 1t Cerebral Palsy or M

    An0iety " panic isorers Et>, +ithra+al .nsomnia tatus epilepticus Anesthesia inuction &elie' o' spasm 1t i

    Adverse Effects:

    CN epression Physical epenence 'rom long-term use

    Contraindications/Precautions:

    Pregnancy (3) Caution F impaire li2er or renal 'unctionInteractions:

    CN epressants (Et>,* opiois* antihistamines* barbiturates)5 Aiti2eepressi2e e''ects +ith concurrent use$

    Education:

  • 8/13/2019 Nervous system meds

    63/110

    Centrally Acting(Muscle #ela1ant Antis$asmodic)

    N203ATI (nit

    Nervous Sys

    Expected Action: Proto: Baclo'en cycloben%aprine m

  • 8/13/2019 Nervous system meds

    64/110

    Expected Action: Proto:Baclo'en* cycloben%aprine* m

    Acts in CN to epress spasticity o' muscles

    Therapeutic Uses: &elie' o' muscle spasm 1t inury

    &elie' o' spasticity r1t cerebral palsy or multiple sclerosisAdverse Effects:

    CN epression Physical epenence 'rom long-term use

    Metaxalone:hepatoto0icity Baclofen5 nausea* urinary retention* co

    Contraindications/Precautions: Caution in patients +ith impaire li2er o

    'unction$ Baclofen5 Pregnancy (C)Interactions: CN epressants (Et>,* opiois* antihistamines) aiti

    epressant e''ects +ith concurrent use$

    Education:

  • 8/13/2019 Nervous system meds

    65/110

    Cue(Muscle #ela1ant Antis$asmodic)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    66/110

    &esponse

  • 8/13/2019 Nervous system meds

    67/110

    eri$herally Acting(Muscle #ela1ant Antis$asmodic)

    N203ATI (nit

    Nervous Sys

    Expected Action: a!e: 3antrolene (3an

  • 8/13/2019 Nervous system meds

    68/110

    Expected Action: a!e:3antrolene (3an

    >nly peripherally acting muscle rela0ant$ .nhibits muscle contraction bypre2enting release o' calcium in skeletal muscles$

    Therapeutic Uses:

    &elie' o' spasticity 1t cerebral palsy or multiple sclerosis

    Treatment o' malignant hyperthermia

    Adverse Effects:

    CN epression ,epatic to0icity

    Contraindications/Precautions:

    Pregnancy (C) Caution +ith impaire li2er " renal

    'unction

    Interactions:

    CN epressants aiti2e e''ects

  • 8/13/2019 Nervous system meds

    69/110

    .ocal Anesthetics

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    70/110

    Expected Action:A!ide type5 iocaine Ester type5 tetrac

    proc

    pain by blocking local conuction o' pain impulsesAdverse Effects:

    CN e0citation -- treat F mia%olam (/erse) oria%epam

    ,ypotension* braycaria* heart block* cariac arrest

    Allergic reactions (more likely F esters)

    uterine contractility$ 4reely cross placenta

    pinal heaache (lay 'lat 'or ;= hrs) 7rinary retention (call a'ter

    hrs)

    Contraindications/Precautions: C. in ysrhythmias an1or heart block

    Caution +ith li2er1kiney ys'unction* heart 'ailure* myasthenia gra2is

  • 8/13/2019 Nervous system meds

    71/110

    'eneral Inhalation Anesthetics

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    72/110

    Expected

    Action:Proto:,alothane (4luothane)* iso'lurane (4orane)* nitrou

    oss o' consciousness* loss o' sensation* rela0ation o' muscles* amnesia

    Adverse Effects: ,epatoto0icity Gastric aspiration ,ypotension &espiratory " cario2ascular epression

    Malignant hyperthermia (1c me* ice or ice saline in'usion* antrolene)

    Interactions:

    CN epressants5 Aiti2e e''ect >piois5 constipation " urinary

    retention

    Education: uccinylcholine use as a muscle rela0ant

    Encourage early ambulation Assist +ith lung e0pansion

  • 8/13/2019 Nervous system meds

    73/110

    Intravenous Anesthetics(4ey oints)

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    74/110

    Barbiturates5 Thiopental (Pentothal) Jetamine (Jetalar)

    Ben%oia%epines5 3ia%epam (/alium)* mia%olam (/erse)* lora%epam

    (Ati2an) Propo'ol (3ipri2an)

    Therapeutic

    Uses: Aunct to inhalation anesthesia

    .nuction " maintenance o' anesthesia Amnesia

    Mia%olam " an opioi result in conscious seation

    Jetamine can be use +ith chilren

  • 8/13/2019 Nervous system meds

    75/110

    Intravenous Anesthetics(ffects and Interactions)

    N203ATI (nit

    Nervous Sys

    Expected Action: Thiopental* 3ia%epam* Jetamine* Propo'ol* Mia%

  • 8/13/2019 Nervous system meds

    76/110

    Adverse Effects:

    &espiratory an cario2ascular epression

    Propofol5 Bacterial in'ection (use opene 2ial +ithin 9 hrs)

    Ketamine5 Psychologic reaction (premeicate +ith ia%epam to risk)

    Contraindications/Precautions:

    Ketamineshoul be a2oie +ith psychiatric isorers

    Interactions:

    CN epressants an stimulants5 Aiti2e e''ects

    >pioi analgesics5 Constipation an urinary retentionEducation:

    Midazolam (Versed):inect o2er K= minutes

    Propofol (Diprivan)5 inect into large 2ein: prep site +ith lidocaine$

  • 8/13/2019 Nervous system meds

    77/110

    Anti$sychotics " Conventional

    N203ATI (nit

    Nervous Sys

    Expected

    Action:

    Proto:D5 chlorproma%ine (Thora%ine)* D5 haloperiol "thers5 'luphena%ine* molinone* perphena%ine* thio

    3 i t l h li hi t i " i h i t i b i

  • 8/13/2019 Nervous system meds

    78/110

    3opamine* acetylcholine* histamine* " norepinephrine receptors in brainperiphery are blocke$ ymptom inhibition 1t opamine#blockae in br

    Therapeutic Uses: 3elusional isorer Bipolar isorer

    Tourettes ynrome chi%oa''ecti2e isor 3ementia chi%ophrenia ,untingtons chorea

    Adverse Effects: Agranulocytosis eation Photosensiti2

    Anticholinergic e''ects >rtho hypotension Neuroenocrine e

    ei%ures Parkinsonism e0ual ys'unction 3ysrhy

    3ystonia Akathisia Tari2e yskinesia Neuroleptic malignant synrome

    Interactions: Anticholinergics5D CN epressants5 Aiti2e e''

    e2oopa5 Counteracts antipsychotics by stimulating opamine receptor

    Education: Consier epot preparations Protect li8ui prep 'rom

    Early EP symptoms +ith anticholinergics*!loc"ers# !enzodiazepines

  • 8/13/2019 Nervous system meds

    79/110

    Anti$sychotics " Aty$ical

    N203ATI (nit

    Nervous Sys

    Expected

    Action:Proto:clo%apine "thers5 risperione* olan%apine* 8ueti

  • 8/13/2019 Nervous system meds

    80/110

    Action results 'rom blockingserotoninan dopaminereceptors (block o

    receptors* too) -- Pr e2eloping EP or tari2e yskinesia

    Therapeutic Uses: e2ere schi%ophrenia

    Psychosis inuce by levodopatherapy

    Adverse Effects: Agranulocytosis (BC

  • 8/13/2019 Nervous system meds

    81/110

    Normal .a, alues

    N203ATI (nit

    Nervous Sys

    &BCQ$R-9$;0 ;;=1 BC O-;0 ;S1 PT ;O-Q0

    P> RO ; PC>

  • 8/13/2019 Nervous system meds

    82/110

    P>#RO-;mm ,g PC>=

  • 8/13/2019 Nervous system meds

    83/110

    Cue

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    84/110

    &esponse

  • 8/13/2019 Nervous system meds

    85/110

    Antide$ressants 5 Tricyclic (TCA

    N203ATI (nit

    Nervous Sys

    Expected Action:Proto:amitriptyline (

    "thers5 imipramine (To'ranil)* o0epin (in

  • 8/13/2019 Nervous system meds

    86/110

    Block reuptake o' norepinephrineanserotoninin synaptic space

    Therapeutic Uses: 3epression " bipolar isorers

    Adverse Effects: >rthostatic hypotension eation Anticholinergic e''ects Cariac to0icity V oses

    To0icity e2ience by ysrhythmias* con'usion* " agitation 'ollo+e bysei%ures

    Contraindications/Precautions: Pregnancy (C)

    Interactions: MA>.s hypertension

    Antihistamine " anticholinergicsaiti2e e''ects

    Epi1Norepi amounts o' arenergics because reuptake is blocke by

    Epherine1amphetamine responses to these 1t uptake inhibition keethem 'rom reaching site o' action in ner2e terminal

    Et>,* ben%oia%epines* opiois* antihistamines Aiti2e CN epress

  • 8/13/2019 Nervous system meds

    87/110

    Selective Serotonin#eu$tae Inhi,itors (SS#Is)

    N203ATI (nit

    Nervous Sys

    Expected

    Action:

    Proto:'luo0etine (Pro%ac) "thers:citalopram (escitalopram (e0apro)* paro0etine (Pa0il)* sertraline

  • 8/13/2019 Nervous system meds

    88/110

    Action: escitalopram (e0apro)* paro0etine (Pa0il)* sertraline

    Block reuptake o'serotoninin synaptic space

    Therapeutic Uses:

    Maor epression

    Panic isorers

    Bulim >C3 PT3 PM33

    Adverse Effects: e0ual ys'unction eight gain &

    ithra+al synrome leepiness* 'aintness ,yponatremi

    erotonin synrome =-R= hrs (con'usion* an0iety* agitation* hallucination

    Contraindications/Precautions: Pregnancy (C)

    C.5 MA>.s

    Interactions: MA>.s risk o' serotonin synrome

    ar'arin +ar'arin le2els TCA " ithium le2els o' thes

    NA.3s " anticoagulants 'luo0etine suppresses platelets bleein

  • 8/13/2019 Nervous system meds

    89/110

    Monoamine -1idase Inhi,itors(MA-I)

    N203ATI (nit

    Nervous Sys

    Expected

    Action:Proto:phenel%ine (Naril) "thers5 isocarb

    Block MA> in brain norepinephrine an serotonin a2ailable 'or imp

    Th i U At i l i >C3 B li i

  • 8/13/2019 Nervous system meds

    90/110

    Therapeutic Uses: Atypical epression >C3 Bulimia

    Adverse Effects: >rthostatic hypotension CN stimulation

    ,ypertensi2e crisis 'rom ietary tyramine (

    ,&*

    BP)5 .nuce 2asoi+ith ./phentolamine(!-blocker) or sublingual nifedipine$

    Contraindications/Precautions:

    C.5 &.s* pheochromocytoma* cario2ascular isease " renal insu''ici

    Interactions: .nirect sympathomimetic release NE causing hypertens

    crisis TCA hypertensi2e crisis &.s serotonin synrome

    Antihypertensi2es aiti2e hypotensi2e e''ect Meperidine

    hyperpyre0ia Tyramine-rich 'oos hypertensi2e crisis (age cheese* salami* a2ocao

    bananas* protein* " re +ine)

    /asopressors (phen$leth$lamine* caffeine)

    hypertension

  • 8/13/2019 Nervous system meds

    91/110

    Aty$ical Antide$ressants

    N203ATI (nit

    Nervous Sys

    E t dProto:bupropion (ellbutrin) "thers:mirta%apine (&em

  • 8/13/2019 Nervous system meds

    92/110

    Expected

    Action:

    p p ( ) p (2enla'a0ine (E''e0or)* rebo0etine (/estra)* tra%o

    .nhibit opamine uptakeTherapeutic Uses: 3epression Ai to 8uit smoki

    Adverse Effects: ei%ures

    ,eaache* ry mouth* constipation* ,&* restlessness* +eight loss

    Contraindications/Precautions:

    Pregnancy B C.5 ei%ure isorers* MA>.s

    Interactions: MA>.s (e$g$phenelzine) risk o' to0icity

  • 8/13/2019 Nervous system meds

    93/110

    Mood Sta,ili+ers

    N203ATI (nit

    Nervous Sys

  • 8/13/2019 Nervous system meds

    94/110

  • 8/13/2019 Nervous system meds

    95/110

    Sedative"/y$notics ""&en+odia+e$ines

    N203ATI (nit

    Nervous Sys

    Expected Action:Proto:ia%epam (/alium) "thers:alpra%olam (W

    lora%epam (Ati2an)* chloria%epo0ie (i

    E h h i ' i b i i (GABA)

  • 8/13/2019 Nervous system meds

    96/110

    Enhance the action o' gamma-aminobutyric aci (GABA)

    Therapeutic Uses: An0iety ei%ures Panic isorer

    Muscle spasms Anesthesia Et>, +1 .nsomAdverse Effects: CN epression Anterograe amne

    Parao0ical response &espiratory epression

    Acute to0icity (treat oral F charcoal* treat ./ Ffl%mazenil)

    Contraindications/Precautions: Teratogenic

    Interactions:

    CN epressants aiti2e e''ects

    Education:

  • 8/13/2019 Nervous system meds

    97/110

    Sedative"/y$noticsNon"&en+odia+e$ine

    N203ATI (nit

    Nervous Sys

    Expected Action:Proto:%olpiem (Ambien) >thers5 %aleplon (

    es%opiclone (unesta) * tra%oone (3

    Enhance action o' GABA in CN leaing to prolonge sleep uration$ T

  • 8/13/2019 Nervous system meds

    98/110

    g p g pnot 'unction as antian0iety* muscle rela0ant* or antiepileptic agents$

    Therapeutic Uses:

    Management o' insomnia

    Adverse Effects:

    3aytime sleepiness an lightheaeness

    Contraindications/Precautions:

    Interactions:

    CN epressants aiti2e e''ects

    4oo absorption +hen taken +ith 'oo

    Education:

  • 8/13/2019 Nervous system meds

    99/110

    An1iolytic 5 Non"&ar,iturate

    N203ATI (nit

    Nervous Sys

    Expected Action: Proto:Buspirone (Bu

    7ncertain it oes bin toserotoninan dopaminereceptors$

  • 8/13/2019 Nervous system meds

    100/110

    p p

    Therapeutic Uses: Treatment o' Generali%e An0iety 3isorer

    Adverse Effects: CN e''ects N> E3AT.>N

    Contraindications/Precautions:

    &r$throm$cin# "etoconazole* an grape'ruit uice e''ects o' buspiron

    3oes N>T potentiate CN epressants

    Interactions:

    Education:

    Take +ith meals to pre2ent gastric irritation

  • 8/13/2019 Nervous system meds

    101/110

    CNS Stimulants

    N203ATI (nit

    Nervous Sys

    Expected

    Action:

    Proto:methylpheniate (&italin) "thers5 amphete0troamphetamine (3e0erine)* Aerall* c

    &elease norepinephrine an opamine an pre2ent their reuptake in CN

  • 8/13/2019 Nervous system meds

    102/110

    &elease norepinephrine an opamine an pre2ent their reuptake in CN

    Therapeutic Uses: A3,3 >besity Narcolepsy

    Adverse Effects: CN stimulation eight loss Cario2ascular e''ects (ysrhythmias* chest pain* BP)

    Contraindications/Precautions:

    Caution5 hyperthyroiism* heart isease* glaucoma* ,0 o' rug abuse* M

    Interactions:

    MA'shypertensi2e crisis

    affeine

    CN stimulant e''ects Phen$toin# *arfarin# pheno!ar!ital.nhibite metabolism o' these

    >TC col " econgestants CN stimulant e''ects

    Education:

  • 8/13/2019 Nervous system meds

    103/110

    %rugs of A,use

    Alcohol

    N203ATI (nit

    Nervous Sys

    %ithdra&al 'y!pto!s 7sually start +ithin ;=-R= hours 1 Persist O-R

    Can be mil5 nausea* an0iety* tremors

    Can be li'e-threatening5 hallucinations* cramps* tremors* sei%ures* ,&

  • 8/13/2019 Nervous system meds

    104/110

    T

    'upport Meds:

    Ben%oia%epines (chlordiazepoxide# diazepam# lorazepam) 3T an

    sei%ures*intensity o' symptoms Auncts (car!amazepine# clonidine# propanolol) sei%ure*cra2in

    epress autonomic response (,&*BP*T)

    Maintenance Meds:

    Dis%lfiram (Anta!%se)F Et>,* alehye synrome occurs (nausea* e0tr2omiting* hypotension) Can progress to respiratory an cariac epresssei%ures* an eath$

    +altrexone (,eVia)>pioi antagonist that cra2ing an pleasurable

    Acamprosate (ampral)unpleasant e''ects o' abstinence (an0iety* e

  • 8/13/2019 Nervous system meds

    105/110

    %rugs of A,use

    -$ioids

    N203ATI (nit

    Nervous Sys

    %ithdra&al 'y!pto!s el'-limiting in R-; ays

    Begins +ith s+eating an rhinorrhea progressing 'rom tremors an irrit

  • 8/13/2019 Nervous system meds

    106/110

    Begins +ith s+eating an rhinorrhea* progressing 'rom tremors an irritto +eakness* nausea* 2omiting* muscle1bone pain* an spasticity$

    N>T li'e-threatening$(etox Meds:

    Methadone substitution Pre2ents +ithra+al synrome$

    Maintenance Meds:

    Methadone ong-term maintenance$ 3epenence is trans'erre tomethaone$

    lonidine (atapres)Control autonomic hyperacti2ity (nausea* 2omiti

    B%prenorphine (-%!%tex)>pioi agonist1antagonist

    +aloxone (-%!oxone)>pioi agonist1antagonist

  • 8/13/2019 Nervous system meds

    107/110

    %rugs of A,use

    Nicotine

    N203ATI (nit

    Nervous Sys

    %ithdra&al 'y!pto!s

    Abstinence synrome is e2ience by irritability ner2ousness restlessn

  • 8/13/2019 Nervous system meds

    108/110

    Abstinence synrome is e2ience by irritability* ner2ousness* restlessn

    'upport Meds: B%propion (.$!an)cra2ing an symptoms o' +ithra+al$

    +icotinePharmaceutical replacement to alle2iate symptoms

    Education

    Che+ gum o2er

  • 8/13/2019 Nervous system meds

    109/110

    N20ATI (

    Nervous S

    Expected Action: Proto:2asopressin (Pitressin) X "thers5 esmopressin (3

    Promote ,=> reabsorption in kineys (esmopressin pre'erre)

  • 8/13/2019 Nervous system meds

    110/110

    Promote ,=> reabsorption in kineys (esmopressin pre'erre)

    /asoconstriction ue to smooth muscle contraction (2asopressin)

    Therapeutic Uses: 3iabetes insipius Cariac arrest

    Adverse Effects: >2erhyration (sleepiness* pouning heaache)

    Contraindications/Precautions: Y (W) Pregnancy

    CA3 orperipheral circulation (risk 'or gangrene)

    Education: Monitor site care'ully: e0tra2asation can cause gangrene$